HER2 Breast Cancer

>

Latest News

FDA Grants Priority Review to T-DXd for HR+, HER2-Low/Ultralow Breast Cancer
FDA Grants Priority Review to T-DXd for HR+, HER2-Low/Ultralow Breast Cancer

October 1st 2024

The application is supported by results from the phase III DESTINY-Breast06 trial.

Wei Assesses Role of TROP2 and HER2 Status in Treatment With Sacituzumab for ER+ mBC
Wei Assesses Role of TROP2 and HER2 Status in Treatment With Sacituzumab for ER+ mBC

September 26th 2024

Overall Survival With Dato-DXd Fails to Meet Significance in Breast Cancer
Overall Survival With Dato-DXd Fails to Meet Significance in Breast Cancer

September 23rd 2024

FDA Approves New Dosage of Trastuzumab Biosimilar for HER2-Overexpressing Cancers
FDA Approves New Dosage of Trastuzumab Biosimilar for HER2-Overexpressing Cancers

September 19th 2024

Pelareorep Plus Paclitaxel Extends Survival in HR+/HER2– Breast Cancer
Pelareorep Plus Paclitaxel Extends Survival in HR+/HER2– Breast Cancer

September 19th 2024

Latest CME Events & Activities

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

View More